0001192482-12-000066.txt : 20120309 0001192482-12-000066.hdr.sgml : 20120309 20120309143939 ACCESSION NUMBER: 0001192482-12-000066 CONFORMED SUBMISSION TYPE: 3 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20120228 FILED AS OF DATE: 20120309 DATE AS OF CHANGE: 20120309 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: HORIZON PHARMA, INC. CENTRAL INDEX KEY: 0001492426 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 272179987 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1033 SKOKIE BLVD STREET 2: SUITE 355 CITY: NORTHBROOK STATE: IL ZIP: 60062 BUSINESS PHONE: 224-383-3000 MAIL ADDRESS: STREET 1: 1033 SKOKIE BLVD STREET 2: SUITE 355 CITY: NORTHBROOK STATE: IL ZIP: 60062 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Quaker BioVentures II LP CENTRAL INDEX KEY: 0001497725 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35238 FILM NUMBER: 12680208 BUSINESS ADDRESS: STREET 1: QUAKER BIOVENTURES STREET 2: 2929 ARCH STREET CITY: PHILADELPHIA STATE: PA ZIP: 19104 BUSINESS PHONE: (215) 988-6800 MAIL ADDRESS: STREET 1: QUAKER BIOVENTURES STREET 2: 2929 ARCH STREET CITY: PHILADELPHIA STATE: PA ZIP: 19104 3 1 edgar.xml PRIMARY DOCUMENT X0204 3 2012-02-28 0 0001492426 HORIZON PHARMA, INC. HZNP 0001497725 Quaker BioVentures II LP 2929 ARCH STREET PHILADELPHIA PA 19104 0 0 1 0 Common Stock 2761477 D Warrants to Purchase Common Stock .01 2012-08-22 2017-01-22 Common Stock 546198 D Warrants to Purchase Common Stock 4.308 2012-02-28 2017-03-02 Common Stock 690369 D The securities are deemed to be beneficially owned by Quaker BioVentures II, L.P., Quaker BioVentures Capital II, L.P. and Quaker BioVentures Capital II, LLC. Quaker BioVentures Capital II, L.P. is the general partner of Quaker BioVentures II, L.P. Quaker BioVentures Capital II, LLC is the general partner of Quaker BioVentures Capital II, L.P. Quaker BioVentures II, L.P., By: Quaker BioVentures Capital II, L.P., its general partner, By: Quaker BioVentures Capital II, LLC, its general partner, By: /s/ Richard S. Kollender, Vice President 2012-03-09